Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Change in Receivables (2021 - 2025)

Keros Therapeutics filings provide 5 years of Change in Receivables readings, the most recent being $75000.0 for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 96.81% to $75000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $825000.0, a 68.26% decrease, with the full-year FY2025 number at $825000.0, down 68.26% from a year prior.
  • Change in Receivables hit $75000.0 in Q4 2025 for Keros Therapeutics, up from -$12.3 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $18.0 million in Q4 2021 to a low of -$18.0 million in Q1 2022.
  • Median Change in Receivables over the past 5 years was $83000.0 (2024), compared with a mean of $274384.6.
  • The widest YoY moves for Change in Receivables: up 17428.92% in 2025, down 3309.38% in 2025.
  • Keros Therapeutics' Change in Receivables stood at $18.0 million in 2021, then tumbled by 200.0% to -$18.0 million in 2022, then surged by 100.79% to $143000.0 in 2023, then surged by 1546.15% to $2.4 million in 2024, then tumbled by 96.81% to $75000.0 in 2025.
  • The last three reported values for Change in Receivables were $75000.0 (Q4 2025), -$12.3 million (Q3 2025), and -$1.5 million (Q2 2025) per Business Quant data.